↓ Skip to main content

Dove Medical Press

Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders

Overview of attention for article published in Vascular Health and Risk Management, November 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

policy
1 policy source
video
1 YouTube creator

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
49 Mendeley